Specifically, only IL-10 + B cells, not whole B-cell populations or IL-10 − B-cell subsets, were able to suppress autoreactive T-cell activation ex vivo and prevent the diabetes progression in vivo. The gene discussed is IL10; the disease is diabetes mellitus.